A RAND study comparing hospital prices across states provided insights into the drivers of high healthcare spending in Michigan, explained Bret Jackson, president of the Economic Alliance for Michigan.
A RAND study comparing hospital prices across states provided insights into the drivers of high healthcare spending in Michigan, explained Bret Jackson, president of the Economic Alliance for Michigan.
Transcript
Michigan recently participated in a RAND study comparing hospital prices for privately insured patients to a Medicare benchmark. What were the results?
The results showed wide variation of hospital prices, especially outpatient prices, across the country. And it was really staggering what the differences were from state to state. Michigan actually fared pretty well in having some of the lowest prices in the country. However, we know that our premiums are above average for the states that are in the study and that total spending of healthcare is high in Michigan. And so, now that we know that prices are low, we know that the problem lies in utilization.
This was version 2.0 of the RAND study. What was the purpose of it and how did it differ from the 1.0 version? What is next?
They had done the study, they had just looked at Indiana, and then afterwards they were like, “Okay, well this seems like it’s high, but we have no idea how that compares to anybody else,” because they had no benchmark. So the 2.0 study was a 25-state study, looking at how Indiana compared to all the other states that participated. Now we’re trying to look at a 3.0 study, where we’re trying for a 50-state strategy so we can compare how everybody’s doing.
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More